GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » OrganoClick AB (OSTO:ORGC) » Definitions » Cyclically Adjusted Revenue per Share

OrganoClick AB (OSTO:ORGC) Cyclically Adjusted Revenue per Share : kr1.25 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is OrganoClick AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

OrganoClick AB's adjusted revenue per share for the three months ended in Mar. 2025 was kr0.361. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr1.25 for the trailing ten years ended in Mar. 2025.

During the past 12 months, OrganoClick AB's average Cyclically Adjusted Revenue Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-30), OrganoClick AB's current stock price is kr1.96. OrganoClick AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr1.25. OrganoClick AB's Cyclically Adjusted PS Ratio of today is 1.57.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OrganoClick AB was 4.43. The lowest was 1.57. And the median was 2.68.


OrganoClick AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for OrganoClick AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganoClick AB Cyclically Adjusted Revenue per Share Chart

OrganoClick AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.14 1.23

OrganoClick AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.19 1.21 1.23 1.25

Competitive Comparison of OrganoClick AB's Cyclically Adjusted Revenue per Share

For the Specialty Chemicals subindustry, OrganoClick AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganoClick AB's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, OrganoClick AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OrganoClick AB's Cyclically Adjusted PS Ratio falls into.


;
;

OrganoClick AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OrganoClick AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.361/132.8245*132.8245
=0.361

Current CPI (Mar. 2025) = 132.8245.

OrganoClick AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.202 99.995 0.268
201509 0.108 100.228 0.143
201512 0.065 100.276 0.086
201603 0.098 100.751 0.129
201606 0.255 101.019 0.335
201609 0.131 101.138 0.172
201612 0.094 102.022 0.122
201703 0.262 102.022 0.341
201706 0.411 102.752 0.531
201709 0.232 103.279 0.298
201712 0.168 103.793 0.215
201803 0.247 103.962 0.316
201806 0.412 104.875 0.522
201809 0.215 105.679 0.270
201812 0.172 105.912 0.216
201903 0.292 105.886 0.366
201906 0.432 106.742 0.538
201909 0.206 107.214 0.255
201912 0.163 107.766 0.201
202003 0.242 106.563 0.302
202006 0.390 107.498 0.482
202009 0.216 107.635 0.267
202012 0.197 108.296 0.242
202103 0.321 108.360 0.393
202106 0.419 108.928 0.511
202109 0.231 110.338 0.278
202112 0.183 112.486 0.216
202203 0.333 114.825 0.385
202206 0.393 118.384 0.441
202209 0.227 122.296 0.247
202212 0.221 126.365 0.232
202303 0.444 127.042 0.464
202306 0.419 129.407 0.430
202309 0.341 130.224 0.348
202312 0.285 131.912 0.287
202403 0.390 132.205 0.392
202406 0.395 132.716 0.395
202409 0.294 132.304 0.295
202412 0.218 132.987 0.218
202503 0.361 132.825 0.361

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


OrganoClick AB  (OSTO:ORGC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OrganoClick AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.96/1.25
=1.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of OrganoClick AB was 4.43. The lowest was 1.57. And the median was 2.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


OrganoClick AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of OrganoClick AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganoClick AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » OrganoClick AB (OSTO:ORGC) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.

OrganoClick AB Headlines

No Headlines